Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M7SY
|
||||
Former ID |
DIB020912
|
||||
Drug Name |
SB269652
|
||||
Synonyms |
SB-269652; SB-269,652
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [532129] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H30N4O
|
||||
InChI |
InChI=1S/C27H30N4O/c28-17-20-5-8-21-12-14-31(18-23(21)15-20)13-11-19-6-9-24(10-7-19)29-27(32)26-16-22-3-1-2-4-25(22)30-26/h1-5,8,15-16,19,24,30H,6-7,9-14,18H2,(H,29,32)/t19-,24-
|
||||
InChIKey |
JGLGOAQPUQITLD-OGAOHHHESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Modulator (allosteric modulator) | [532915] | |
D(3) dopamine receptor | Target Info | Modulator (allosteric modulator) | [533107] | ||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
Nicotine Activity on Dopaminergic NeuronsWP58:Monoamine GPCRs | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.